Additionally, ongoing research continues to explore the TMPRSS2:ERG fusion gene for its potential as a different biomarker, therapeutic target, and diagnostic and prognostic indicator in PCa (121). The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.